Can CT imaging features be used to evaluate the risk stratification of non-muscle-invasive bladder cancer?

Key Points

• CT imaging features can effectively stratify risk in non-muscle-invasive bladder cancer patients, enhancing management strategies.
• Key evidence indicates that using specific tumor characteristics improves prediction accuracy and patient selection.
• Analysis of imaging data from multiple cohorts demonstrates the utility of biomarkers in assessing tumor risk levels.
• This research may enable more personalized treatment pathways, although additional validation studies are necessary for clinical implementation.